Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Mileshkin

Showing results (1-10 of 174) with videos related to

Pageof 18
Sort By:
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
What constitutes a multidisciplinary team meeting?Linda Mileshkin, John Zalcberg
Journal of Law and Medicine|February 11, 2012
Access to expensive anti-cancer drugsLinda Mileshkin, Danny Sullivan
Leukemia & Lymphoma|November 17, 2006
The troublesome toxicity of peripheral neuropathy with thalidomideLinda Mileshkin, H Miles Prince
Leukemia & Lymphoma|July 16, 2005
The adverse prognostic impact of advanced age in multiple myelomaLinda Mileshkin, H Miles Prince
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?Emma Beardsley, Michael Jefford, Linda Mileshkin
The New England Journal of Medicine|February 17, 2012
Adjuvant trastuzumab in HER2-positive breast cancerIan Collins, Prudence Francis, Linda Mileshkin
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 4, 2011
Patients' understanding of clinical trials needs to be assessed in the context of understanding of overall goals of careJaclyn Yoong, Michael Jefford, Linda Mileshkin
The New England Journal of Medicine|October 19, 2012
Early cardiovascular death in patients with cancerMark Voskoboynik, Damien Urban, Linda Mileshkin
Chemotherapy Research and Practice|June 6, 2012
Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?Linda Mileshkin, Bhaumik Shah, Michael Michael
Drugs & Aging|September 28, 2007
Treatment strategies in elderly patients with multiple myeloma: current statusHang Quach, H Miles Prince, Linda Mileshkin
Pageof 18

Showing results (1-10 of 174) with videos related to

Sort By:
Pageof 18
Asia-Pacific Journal of Clinical Oncology|September 3, 2011
What constitutes a multidisciplinary team meeting?Linda Mileshkin, John Zalcberg
Journal of Law and Medicine|February 11, 2012
Access to expensive anti-cancer drugsLinda Mileshkin, Danny Sullivan
Leukemia & Lymphoma|November 17, 2006
The troublesome toxicity of peripheral neuropathy with thalidomideLinda Mileshkin, H Miles Prince
Leukemia & Lymphoma|July 16, 2005
The adverse prognostic impact of advanced age in multiple myelomaLinda Mileshkin, H Miles Prince
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Longer consent forms for clinical trials compromise patient understanding: so why are they lengthening?Emma Beardsley, Michael Jefford, Linda Mileshkin
The New England Journal of Medicine|February 17, 2012
Adjuvant trastuzumab in HER2-positive breast cancerIan Collins, Prudence Francis, Linda Mileshkin
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 4, 2011
Patients' understanding of clinical trials needs to be assessed in the context of understanding of overall goals of careJaclyn Yoong, Michael Jefford, Linda Mileshkin
The New England Journal of Medicine|October 19, 2012
Early cardiovascular death in patients with cancerMark Voskoboynik, Damien Urban, Linda Mileshkin
Chemotherapy Research and Practice|June 6, 2012
Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside?Linda Mileshkin, Bhaumik Shah, Michael Michael
Drugs & Aging|September 28, 2007
Treatment strategies in elderly patients with multiple myeloma: current statusHang Quach, H Miles Prince, Linda Mileshkin
Pageof 18